
Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness.
16 Gulick TS, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte.
Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-α.
14 Franco F, Thomas GD, Giroir BP, Bryant D, Bullock MC, Chwialkowski MC, Victor RG, Peshock RM. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. 13 Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS.
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.
12 Natanson C, Eichenholz PW, Danner RL, Eichacker W, Hoffman D, Kuo SM, Banks TJ, MacViottie TJ, Parrillo JE. Shock and tissue injury induced by recombinant human cachectin. 11 Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD, Shires GT. Basic mechanisms in heart failure: the cytokine hypothesis. 10 Seta Y, Shan K, Bozkurt B, Oral H, Mann DL. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-α. 9 Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM. Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. 8 Thaik CM, Calderone A, Takahashi N, Colucci WS. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. 7 Bozkurt B, Kribbs S, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL. Tumor necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration. 6 Kapadia S, Lee JR, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β. 5 Pomerantz BJ, Reznikov LL, Harken AH, Dinarello CA. Infliximab harmful in CHF - final results of ATTACH. RENEWAL trial: no improvement in CHF with etanercept.
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. 2 Levine B, Kalman J, Mayer L, Fillit HM, Packer M.Tractatus de Corde: De Motu & Colore Sagnuinus et Chyli in Eum Tranfitu. Customer Service and Ordering Information.Stroke: Vascular and Interventional Neurology.Journal of the American Heart Association (JAHA).Circ: Cardiovascular Quality & Outcomes.Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB).